Acute monoarthritis (1:30), improving adverse drug reaction reporting (6:30), inappropriate use of oral antiplatelet drugs (9:50), long-term opioid therapy (12:40), treating Clostridioides difficile infection (17:10), and lecanemab for Alzheimer disease (19:00).